Compound amino acid feed processing technology

Compound amino acid feed processing technology

In recent years, due to crop failures, especially due to the poor harvest of soybeans, beverage prices have risen (bean pods have risen to around 3,000 per ton). Farmers and feed farmers can not afford to suffer. After many years of research, researchers at Hebei University have developed new amino acid feeds that are characterized by low cost, easy absorption, and strong addictiveness. They are the ideal replacements for soybean meal and fishmeal. The advent of this product is the best project to solve the win-win situation of producers and users. Compound amino acid feed processing is different from other projects. It has high technology content, simple process, clean and sanitary, no special factory building, general house can be, simple equipment, easy operation, low labor intensity, monthly production of 60 tons. Small-scale production requires only two workers and covers an area of ​​40 square meters. The investment in equipment does not exceed 2,000 yuan. First, the process of mixing - sifting - bagging - sealing - finished product 2, simple equipment 1, mixer 2, crusher 3, iron sieve 4, sealing machine above equipment is the smallest production or family sideline production, investment How much depends on the situation, the existing ones can be used. Third, the production of raw materials 1, the core material: FH activator. 2, important raw materials: FHAA refined powder 3, high protein raw materials: skin powder, meat powder, blood meal, vermicelli protein. 4, low protein raw materials: alcohol, molting, grass powder, corncob powder, corn stover powder, pomace, sesame oil residue, pomace, peanut shell, sweet potato vine, planted pure protein. Fourth, the principle of production: According to the protein content of protein raw materials of high protein raw materials, the protein content of low protein raw materials, to adjust the protein content of the desired product, and then add the core raw materials, important raw materials, stir evenly. V. Simple Benefits Analysis China's annual feed protein gap is about 50 million tons, and the protein feed remains high, thus creating a good opportunity for the development of compound amino acid feed. 1, 40% compound amino acid feed, semi-finished raw material cost is about 1200 yuan per ton, and the equivalent replacement soybean meal is not about 3000 per ton. 2,55% compound amino acid feed, semi-finished raw material cost is about 4,000 yuan each. 3, enhanced: 60% compound amino acid feed, semi-finished raw material cost is about 4,000 yuan per ton, equivalent to replace the imported fishmeal, the overall efficiency is good, imported fish meal is more than 6,000 yuan per ton. Six, product characteristics: 1, layer chickens and cows can be extended 1-2 months of growth, pigs can be slaughtered 10 days in advance. 2, willing to have hydrolyzed protein aroma and umami, addictive strong (this product is divided brown, yellow, brown and yellow color species). 3, improve the fertilization rate, hatching rate, birth rate, survival rate. 4, significantly reduce the layer of feathers, licking anal phenomenon. 5, can prevent or alleviate the chicken diarrhea, the egg looks good, egg weight increases, pig hair is shiny, snooze does not love moving. VII. Usage: This product can be added to the diet. 40% of crude protein amino acid feed replaces soybean meal, 55% of crude protein amino acid feed replaces soybean meal, and 55% of crude protein amino acid feed replaces fish meal.

Anticancer pharmceuticals are used to make anticancer drugs. Such as Imatinib Mesilate, Ibrutinib, and Lapatinib. Within the past 2 years, four separate groups have reported marked improvement in relapse-free survival when trastuzumab was added to adjuvant chemotherapy in patients with HER2-overexpressing breast cancer.

Lapatinib 

Imatinib (also known as [Gleevec" or [Glivec"), a tyrosine kinase inhibitor, was called as [magical bullet," when it revolutionized the treatment of chronic myeloid leukemia (CML) in 2001. Nano-encapsulation of imatinib mesylate increases its efficacy against cancer cells, with almost no cardiotoxicity.

Lapatinib is a tyrosine kinase inhibitor which can effectively inhibit the tyrosine kinase activity of human epidermal growth factor receptors 1 and 2 (ErbB1, ErbB2). It can uniquely act in a variety of ways, ensuring that breast cancer cells cannot receive growth signals.


Anticancer/Antitumor/Antineoplastic

Anticancer Active Ingredient,Xalkori Anticancer Pharm Intermediate,Lapatinib Raw Materical,Ibrutinib N-1 Intermediate Anticancer

Jinan Jianfeng Chemical Co., Ltd. , http://www.pharmachemm.com